+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
UCB (Union chimique belge) - logo

UCB is a global biopharmaceutical company that focuses on neurology and immunology. The company’s core products are Cimzia, Vimpat, Neupro, Keppra and Briviact, and they are also preparing the launch of a potential medicine to help patients with osteoporosis. It offers products for the treatment of central nervous system disorders, allergy and respiratory diseases, and immune and inflammatory disorders. UCB employs over 7,000 people and is based in Brussels, Belgium.

Drug Manufacturing Sector Scorecard - Thematic Intelligence - Product Thumbnail Image

Drug Manufacturing Sector Scorecard - Thematic Intelligence

  • Report
  • October 2022
  • 23 Pages
  • Global
From
Skin Rash Treatment - Global Strategic Business Report - Product Thumbnail Image

Skin Rash Treatment - Global Strategic Business Report

  • Report
  • October 2025
  • 384 Pages
  • Global
From
Antithrombotic Drugs - Global Strategic Business Report - Product Thumbnail Image

Antithrombotic Drugs - Global Strategic Business Report

  • Report
  • October 2025
  • 282 Pages
  • Global
From
From
Connective Tissue Diseases - Global Strategic Business Report - Product Thumbnail Image

Connective Tissue Diseases - Global Strategic Business Report

  • Report
  • October 2025
  • 385 Pages
  • Global
From
Psoriatic Arthritis Treatment - Global Strategic Business Report - Product Thumbnail Image

Psoriatic Arthritis Treatment - Global Strategic Business Report

  • Report
  • October 2025
  • 452 Pages
  • Global
From
Ankylosing Spondylitis - Global Strategic Business Report - Product Thumbnail Image

Ankylosing Spondylitis - Global Strategic Business Report

  • Report
  • October 2025
  • 271 Pages
  • Global
From
Gastrointestinal Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Gastrointestinal Therapeutics - Global Strategic Business Report

  • Report
  • October 2025
  • 193 Pages
  • Global
From
Diverticulitis Disease - Global Strategic Business Report - Product Thumbnail Image

Diverticulitis Disease - Global Strategic Business Report

  • Report
  • October 2025
  • 294 Pages
  • Global
From
Non-cancerous Skin Diseases Therapeutics Market 2025-2029 - Product Thumbnail Image

Non-cancerous Skin Diseases Therapeutics Market 2025-2029

  • Report
  • February 2025
  • 222 Pages
  • Global
From
Interstitial Cystitis - Pipeline Insight, 2025 - Product Thumbnail Image

Interstitial Cystitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Dermatological Drugs Market 2024-2028 - Product Thumbnail Image

Dermatological Drugs Market 2024-2028

  • Report
  • July 2024
  • 139 Pages
  • Global
From
Loading Indicator